QA: ARRAY BIOPHARMA INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001100412_2018_ARRAY_BIOPHARMA_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001100412')"}

Graph

Absolute values for 0001100412, ARRAY BIOPHARMA INC

  xvar xval
0 AssetsCurrent 270,177,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,132,000
3 remainder_Assets 836,000
4 LiabilitiesCurrent 69,551,000
5 LiabilitiesNoncurrent 197,867,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 35,395,000
8 SellingGeneralAndAdministrativeExpense 39,336,000
9 ResearchAndDevelopmentExpense 178,199,000
10 remainder_Expenses 0
11 remainder_Revenues 150,852,000
12 remainder_NetIncome -14,740,000
13 remainder_ComprehensiveNetIncome -83,000
  yvar yval
0 Assets 279,145,000
1 Liabilities 267,418,000
2 Expenses 252,930,000
3 Revenues 150,852,000
4 StockholdersEquity 11,727,000
5 NetIncome -116,818,000
6 ComprehensiveNetIncome -116,859,500
7 BaseVar 482,584,000
8 EconomicCapitalRatio -0.354

Edgar->Model Mapping

Feature Distribution

Change over Time